162 related articles for article (PubMed ID: 4990004)
41. [Effect of the antibiotic bruneomycin on the peripheral blood and hematopoiesis in animals].
Vertogradova TP
Antibiotiki; 1966 Dec; 11(12):1090-4. PubMed ID: 5998698
[No Abstract] [Full Text] [Related]
42. Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.
Schiller G; Nimer S; Vescio R; Lieb G; Lee M; Gajewski J; Territo M; Berenson J
Bone Marrow Transplant; 1994 Jul; 14(1):131-6. PubMed ID: 7951100
[TBL] [Abstract][Full Text] [Related]
43. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
[TBL] [Abstract][Full Text] [Related]
44. [Hematopoiesis in chronic heliotrine poisoning in Wistar albino rats].
Levin GS; Novachenko ZI
Farmakol Toksikol; 1969; 32(2):170-1. PubMed ID: 5772142
[No Abstract] [Full Text] [Related]
45. Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
Vanásek J; Filip S; Medková V; Bláha M; Maricka P; Stránský P; Vavrová J
Neoplasma; 2001; 48(1):34-8. PubMed ID: 11327535
[TBL] [Abstract][Full Text] [Related]
46. [Phagocytosis of erythroblasts by bone marrow reticular cells in rats with chronic heliotrine poisoning].
Levin GS; Novachenko ZI
Patol Fiziol Eksp Ter; 1968; 12(6):58-61. PubMed ID: 5744110
[No Abstract] [Full Text] [Related]
47. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
[TBL] [Abstract][Full Text] [Related]
48. Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.
Denine EP; Harrison SD; Peckham JC
Cancer Treat Rep; 1977; 61(3):409-17. PubMed ID: 872140
[No Abstract] [Full Text] [Related]
49. Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue.
Spitzer TR; Cirenza E; McAfee S; Foelber R; Zarzin J; Cahill R; Mazumder A
Bone Marrow Transplant; 1995 Apr; 15(4):537-42. PubMed ID: 7655378
[TBL] [Abstract][Full Text] [Related]
50. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Hofland KF; Thougaard AV; Sehested M; Jensen PB
Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
[TBL] [Abstract][Full Text] [Related]
51. [Unrelated match bone marrow transplantation for severe aplastic anemia].
Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A
Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334
[TBL] [Abstract][Full Text] [Related]
52. Acute side effects of homologous interleukin-3 in rhesus monkeys.
van Gils FC; Mulder AH; van den Bos C; Burger H; van Leen RW; Wagemaker G
Am J Pathol; 1993 Dec; 143(6):1621-33. PubMed ID: 8256852
[TBL] [Abstract][Full Text] [Related]
53. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
54. Temporal thrombocytopenia after engraftment with defined stem cells with long-term marrow reconstituting activity.
Bradford G; Williams N; Barber L; Bertoncello I
Exp Hematol; 1993 Dec; 21(13):1615-20. PubMed ID: 7902290
[TBL] [Abstract][Full Text] [Related]
55. Complications of peripheral blood stem cell transplantation.
Klumpp TR
Semin Oncol; 1995 Jun; 22(3):263-70. PubMed ID: 7777870
[No Abstract] [Full Text] [Related]
56. [Effect of asazol and phenesterin on the hemopoiesis of monkeys].
Degteva SA; Platonova GN
Farmakol Toksikol; 1968; 31(4):470-2. PubMed ID: 4972356
[No Abstract] [Full Text] [Related]
57. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
[TBL] [Abstract][Full Text] [Related]
58. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation.
Maschan AA; Kryzanovskii OI; Yourlova MI; Skorobogatova EV; Pashanov ED; Potapova YE; Timonova LA; Bogatcheva NY; Samochatova EV; Roumjantzev AG
Bone Marrow Transplant; 1997 Feb; 19(4):385-7. PubMed ID: 9051250
[TBL] [Abstract][Full Text] [Related]
59. Cyclophosphamide-induced cardiomyopathy during bone marrow transplantation for severe aplastic anemia.
Mehta J; Singhal S; Or R
J Assoc Physicians India; 1994 Feb; 42(2):159-60. PubMed ID: 7860483
[No Abstract] [Full Text] [Related]
60. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
